0

Specific Inhibition of Hepatitis C Virus Entry Into Host Hepatocytes by Fungi-Derived Sulochrin and Its Derivatives

Syo Nakajima, Koichi Watashi, Shinji Kamisuki, Senko Tsukuda, Kenji Takemoto, Mami Matsuda, Ryosuke Suzuki, Hideki Aizaki, Fumio Sugawara, Takaji Wakita

Biochem Biophys Res Commun. 2013 Nov 1;440(4):515-20.

PMID: 24099774

Abstract:

Hepatitis C virus (HCV) is a major causative agent of hepatocellular carcinoma. Although various classes of anti-HCV agents have been under clinical development, most of these agents target RNA replication in the HCV life cycle. To achieve a more effective multidrug treatment, the development of new, less expensive anti-HCV agents that target a different step in the HCV life cycle is needed. We prepared an in-house natural product library consisting of compounds derived from fungal strains isolated from seaweeds, mosses, and other plants. A cell-based functional screening of the library identified sulochrin as a compound that decreased HCV infectivity in a multi-round HCV infection assay. Sulochrin inhibited HCV infection in a dose-dependent manner without any apparent cytotoxicity up to 50 μM. HCV pseudoparticle and trans-complemented particle assays suggested that this compound inhibited the entry step in the HCV life cycle. Sulochrin showed anti-HCV activities to multiple HCV genotypes 1a, 1b, and 2a. Co-treatment of sulochrin with interferon or a protease inhibitor telaprevir synergistically augmented their anti-HCV effects. Derivative analysis revealed anti-HCV compounds with higher potencies (IC50<5 μM). This is the first report showing an antiviral activity of methoxybenzoate derivatives. Thus, sulochrin derivatives are anti-HCV lead compounds with a new mode of action.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP519573 Sulochrin Sulochrin 519-57-3 Price
qrcode